Latest news with #Mentaily
Yahoo
12-05-2025
- Health
- Yahoo
Mentaily raises $3m for genAI mental health diagnostic
Israeli startup Mentaily has raised $3m in seed financing to advance the development of LIV, a mental health diagnosis and support tool. Underpinned by generative artificial intelligence (genAI), LIV is a chat tool that offers personalised support to individuals struggling with PTSD, psychological trauma, and other mental health conditions. Mentaily describes LIV as a simulator of clinical psychiatric intake sessions that is intended to fill clinical gaps in areas with inadequate mental health services. Developed at the ARC Innovation Center and the Drora and Pinchas Zakai department of psychiatry at Israel's Sheba Medical Center in collaboration with Microsoft and KPMG, individuals can communicate with LIV through voice or text chats via mobile or desktop portals. LIV provides evidence-based recommendations for diagnosis and treatment plans for mental health conditions, with the tool able to generate clinical summaries, adjust to individual personality, culture, and origin based on previous user interactions, and integrate with users' electronic medical records (EHR), with the tool designed to be HIPAA compliant. With LIV's AI connected to a validated psychiatric database and due to its machine learning capabilities, Mentaily stated that it is also able to incorporate the latest AI decisioning models and includes a chain of thought process builder, enabling clinicians to define decision-making algorithms and workflows while ensuring transparency and explainability of AI's reasoning. The seed round was led by unnamed US and Israeli family offices, with participation from Israeli impact funds the Rashi Foundation and Sheatufim. A range of unnamed angel investors also participated. According to Mentaily, LIV's name symbolises 'life, resilience, and recovery' and was conceived in response to the aftermath of the Hamas-led terrorist attack on Israel on 7 October 2023. The company said the new funding will support the expansion of LIV, which is already in use in select facilities such as hospitals and rehabilitation centres across Israel, to further local and international markets. Mentaily CEO Iris Shtein commented: 'LIV enables real-time detection of deterioration and high-risk situations, allowing clinical teams to intervene early, with precision. 'Our scalable platform not only enhances access and accuracy, but also empowers systems to prioritise care where it's needed most, transforming psychiatric triage at a national and global level.' Professor Eyal Zimlichman, founder and director of ARC and chief transformation and AI officer at Sheba Medical Center said that LIV's ability to identify, prioritise, and assess mental health conditions makes it a 'promising tool' for health systems worldwide. "Mentaily raises $3m for genAI mental health diagnostic" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
12-05-2025
- Business
- Associated Press
Mentaily Raises $3M in Seed Funding to Transform Psychiatric Intervention Through AI-Powered Diagnosis and Support
GenAI Platform LIV Delivers Personal and Accurate Mental Health Response, Expanding the Pipeline of Pioneering Technologies from ARC at Sheba Medical Center RAMAT GAN, ISRAEL, May 12, 2025 / / -- Mentaily, the creator of AI-powered tools for mental health assessment, triage, and diagnosis of mental disorders, announced today the closing of a $3 million seed funding round. The round was led by a US-based family office and Israeli family offices, with participation from impact funds The Rashi Foundation and Sheatufim, and prominent digital health angel investors. Founded in 2024, Mentaily aims to address complex mental health needs emerging in times of crisis and trauma. The company's first AI-powered product, LIV, simulates clinical psychiatric intake sessions and helps diagnosis psychological distress and mental illness, with high accuracy. Mental health conditions are on the rise globally, yet support remains limited. In the United States alone, an estimated one in five people are affected by mental health issues, while over 120 million Americans live in areas with inadequate mental health services, highlighting the urgent need for new technologies to augment existing mental health interventions. The AI platform supports multilingual, natural-language conversations through voice or text, optionally featuring AI avatar to deliver a personalized and scalable approach to mental health triage. The technology was created as a joint effort between ARC (Accelerate, Redesign, Collaborate) Innovation Center and the Drora and Pinchas Zakai Department of Psychiatry at Sheba Medical Center, along with Microsoft and KPMG. In addition to serving the general population, LIV supports security forces through collaborations with the Directorate of Defense Research & Development (DDR&D) and Israel's Ministry of Defense—addressing the needs of a population often affected by high stress and prolonged trauma. Future versions of the platform will be customized for additional populations, including children, adolescents, and women. Already in use across hospitals, HMOs, rehabilitation centers, and government organizations across Israel, the new funding will support ongoing development and drive expansion both locally and into select international markets. Mentaily was founded by Iris Shtein, who serves as the company's CEO, Guy Yachin, a serial Israeli-American entrepreneur, and senior clinicians from Sheba Medical Center: Prof. Mark Weiser, Dr. Asaf Caspi, and Dr. Daniel Cohen. The company is actively recruiting to support its expansion. 'At Mentaily, our mission goes beyond innovation—it's about solving real-world challenges in mental health care,' said Iris Shtein, CEO and Co-Founder of Mentaily. 'LIV enables real-time detection of deterioration and high-risk situations, allowing clinical teams to intervene early, with precision. By supporting clinical decision-making and optimizing workforce allocation, we help address the global shortage of mental health professionals. Our scalable platform not only enhances access and accuracy, but also empowers systems to prioritize care where it's needed most, transforming psychiatric triage at a national and global level.' 'LIV is a prime example of innovation born from clinicians on the ground, developed through collaboration with additional players in the ecosystem: developers, international tech leaders, and business strategists,' said Prof Eyal Zimlichman, Founder and Director of ARC, Chief Transformation and Chief AI Officer at Sheba Medical Center. 'LIV's ability to identify, prioritize, and assess mental health conditions with accuracy and empathy makes it a promising tool for health systems worldwide. Another successful digital health platform in our growing portfolio, the solution is well aligned with ARC's multi-faceted approach of responsibly and effectively developing and integrating AI into workflows of health systems globally.' ### About Mentaily Mentaily was founded in 2024 by Iris Shtein (CEO), Guy Yachin, Prof. Mark Weiser, Dr. Asaf Caspi, and Dr. Daniel Cohen, with a mission to improve access to mental health services through technology that enables an accessible, personalized, and empathetic diagnostic process. The company was created out of world-renowned Sheba Medical Center with the belief that addressing Israel's mental health crisis, particularly in regions affected by trauma, can create a model for other countries. The name LIV symbolizes life, resilience, and recovery, in response to the aftermath of the October 7th attacks. Mentaily's approach combines personalized medicine, advanced technology, and sensitivity, with the goal of delivering an empathetic solution that is accessible worldwide. About ARC ARC (Accelerate, Redesign, Collaborate), the innovation arm of Sheba Medical Center, founded and directed by Prof. Eyal Zimlichman, is shaping the future of medical innovation by connecting entrepreneurs and clinicians, advancing the development and implementation of new technologies, and creating breakthrough economic frameworks in healthcare. ARC's unique model—the first of its kind in global healthcare—has positioned evolved into a global blueprint, with a network of innovation centers in leading hospitals and research institutions across London, Melbourne, Singapore, Berlin, and New Zealand. ARC's global network promotes technology-based medical solutions and accelerates the adoption of innovation within health systems worldwide. ARC provides startups and researchers with exclusive access to Sheba's core assets, clinical data and medical talent, while advancing the hospital's vision to serve as a global hub for AI-driven medicine. The model's success has already led to exits totaling approximately $1 billion, with profits reinvested to further accelerate Sheba's AI and data revolution. About Sheba Medical Center The largest and most comprehensive medical center in the Middle East, Sheba Medical Center, Tel Hashomer is generating global impact through its medical care, research and AI-based healthcare transformation. Sheba's City of Health boasts acute-care, rehabilitation, children's, cancer and geriatric hospitals, research and innovation hubs, medical simulation center, center for disaster response and a virtual hospital on one comprehensive campus in the center of Israel. Sheba serves as a true hospital without borders, welcoming patients and healthcare professionals from all over the world and consistently providing the highest-level medical care to all in need. For more information, visit: Aviva Sapir Number 10 Strategies [email protected] Visit us on social media: LinkedIn Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
